Announcements Trials
Browse Landscape

Phase

Phase 4 26Phase 3 19Phase NA 17Phase 2 13Phase 1/2 3Phase 1 2Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1Infratentorial Neoplasms 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Fentanyl × Clear all
NCT06953453 2025-09-25

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

Lee's Pharmaceutical Limited

Phase 1 Recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04955236 2022-04-07

Partial Scalp Block in Posterior Fossa Surgery

Kasr El Aini Hospital

Phase 1 Completed
40 enrolled

Infratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡